$ALNY
Alnylam Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$221.07
▲+0.61%+$1.35
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAlnylam Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is ALNY up today? It is at $221.07 (+0.61%), and our scanner flagged it 91 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ALNY spikes, and full due diligence on ALNY — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ALNY 91 times in the last 30 days. Create a free account to track $ALNY, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ALNY is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on ALNY today, peaking at 11.7x its normal volume. A recent catalyst in the news: “Type 2 Diabetes Market to Grow Significantly During the Forecast Period (2026–2036), with Rising Prevalence and Increasing Uptake of Next-Generation Therapies | DelveInsight.” Early read: bullish.
We could not reach SEC EDGAR, so the dilution check did not run. This is not a clean result - verify on EDGAR before trading.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Greenstreet Yvonne Officer | Acquired (grant/award) | +107 | added 0.1% | 96K | n/a | Sep 19, 26 |
Pyott David E I Director | Sold (automatic/other) | -4K | sold 71% | 2K | $1.1M at $297.71 | Jun 1, 26 |
Pyott David E I Director | Other | 4K | added 100% | 5K | n/a | Jun 1, 26 |
Arbuckle Stuart A Director | Acquired (grant/award) | +671 | n/a | 671 | n/a | May 20, 26 |
Ausiello Dennis A Director | Acquired (grant/award) | +671 | added 74% | 2K | n/a | May 20, 26 |
Brandicourt Olivier Director | Acquired (grant/award) | +671 | added 87% | 1K | n/a | May 20, 26 |
Hamburg Margaret A Director | Acquired (grant/award) | +671 | added 74% | 2K | n/a | May 20, 26 |
Kellogg Peter N Director | Acquired (grant/award) | +671 | added 87% | 1K | n/a | May 20, 26 |
Pyott David E I Director | Acquired (grant/award) | +671 | added 74% | 2K | n/a | May 20, 26 |
Reitan Colleen F Director | Acquired (grant/award) | +671 | added 87% | 1K | n/a | May 20, 26 |
Schulman Amy W Director | Acquired (grant/award) | +838 | added 3.6% | 24K | n/a | May 20, 26 |
Sigal Charles Elliott Director | Acquired (grant/award) | +671 | added 87% | 1K | n/a | May 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
ALNY is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on ALNY today, peaking at 11.7x its normal volume. A recent catalyst in the news: “Type 2 Diabetes Market to Grow Significantly During the Forecast Period (2026–2036), with Rising Prevalence and Increasing Uptake of Next-Generation Therapies | DelveInsight.” Early read: bullish.
ALNY last traded at $221.07, up 0.61% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Alnylam Pharmaceuticals, Inc. (ALNY) is next expected to report earnings on Thursday, October 29, 2026, about 24 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ALNY Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ALNY 91 times in the last 30 days.
ALNY (Alnylam Pharmaceuticals, Inc.) trades on XNAS, with a market cap of about $29.40B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ALNY for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ALNY discussion
Sign in to ask a question or join the discussion.